ArticleFrontiers in endocrinology2026
Overt and subclinical hypothyroidism during pregnancy: effects on neonatal amino acids, acylcarnitines, and TSH levels.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background/objectives: Maternal hypothyroidism during pregnancy, including overt and subclinical hypothyroidism, is a common endocrine disorder complicating pregnancy and is associated with increased risks of adverse maternal and fetal outcomes. However, its effects on neonatal metabolism remain inadequately understood. This study aimed to assess the association between hypothyroidism in pregnancy and neonatal amino acid and acylcarnitine levels. Methods: This retrospective case-control study included 1,987 pregnant women with overt hypothyroidism in pregnancy, 2,023 with subclinical hypothyroidism in pregnancy, and 2,043 euthyroid pregnant women from Fujian Provincial Maternity and Children's Hospital between 2016 and 2024. Their newborns all underwent newborn screening for 11 amino acids and 31 acylcarnitines using tandem mass spectrometry. Results: After adjusting for potential confounding factors including gestational age at delivery, birth weight, and neonatal sex, newborns born to mothers with hypothyroidism in pregnancy (overt and subclinical) showed significant differences in the levels of 9 amino acids compared with those born to mothers with normal thyroid function. These amino acids are involved in the arginine-proline metabolism, glycine metabolism, and the urea cycle pathway. Amino acid levels also differed between the two subtypes. In addition, the levels of short-chain, medium-chain, and long-chain acylcarnitines in newborns from the hypothyroidism groups were significantly higher than those in the control group, with several acylcarnitine indicators (C16, C16:1, C16OH, C18:1OH, and C6DC) exhibiting characteristic differences between the two subtypes. The levels of thyroid-stimulating hormone (TSH) in newborns from both hypothyroidism groups were significantly higher than those in the control group, whereas no statistically significant difference in TSH levels was observed between the overt and subclinical hypothyroidism groups. Conclusion: Our findings revealed a significant association between hypothyroidism in pregnancy (overt and subclinical) and neonatal amino acid and acylcarnitine levels, which were mainly involved in branched-chain amino acid, arginine, proline, and glycine metabolism, as well as the urea cycle and fatty acid oxidation pathways. These results underscore the importance of identifying maternal conditions that correlate with neonatal metabolites, providing a reference for exploring strategies to optimize neonatal nutrition and improving long-term health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.